Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Moodys
Harvard Business School
Colorcon
Merck

Last Updated: November 16, 2019

DrugPatentWatch Database Preview

Litigation Details for Baker v. Pfizer, Inc. (W.D. Tenn. 2010)

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Baker v. Pfizer, Inc.
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Baker v. Pfizer, Inc. (W.D. Tenn. 2010)

Date Filed Document No. Description Snippet Link To Document
2011-03-28 57 Order Dismissing Case be marked with United States patent number 4,375,547 (“the ‘547 Patent”). (Id. ¶ 15.) Plaintiff alleges…United States patent numbers: 3,929,821 and 4,080,461 (“the ‘821 Patent” and “the ‘461 Patent,” respectively…products with various United States patent numbers, even though these patents are expired. (Id. ¶ 2.) Plaintiff…that both of these patents have expired, Defendants continue to use the improper patent markings on Synanthic…applying for and obtaining patents, and therefore Defendants know that patents do not have an indefinite External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Merck
Harvard Business School
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.